Peanut allergy skin patch for toddlers shows promise, study finds
According to a peer-reviewed study released on Wednesday, a skin patch being developed by a French pharmaceutical company to treat Peanut allergy skin patches is promising in children. The “peanut patch” fared better than a placebo at “desensitizing children to peanuts and increasing the peanut dose that triggered allergic symptoms,” according to a study supported by DBV Technologies and printed in the New England Journal of Medicine. Peanut Patch Three hundred and sixty-two (1–3)-year-old peanut-allergic children from eight different nations, including the US, Canada, and Australia, participated in the trial. The majority of the toddlers who did not complete the experiment were withdrawn by their parents or guardian, with just about 85% of them. Between their shoulder blades, for a year, a toddler wore either the peanut patch (which contained 250 micrograms of peanut protein, or roughly 1/1,000th of a peanut) or a placebo patch. By the end of the year, two-thirds of the kids who...